PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER FROM ACTIVE BEGINNINGS OF [PSIDIUM] GUAJAVA L.
NOVELTY – The method involves selecting plant species, particularly Psidium guajava L., and obtaining the crude extract of Psidium guajava L. by treating Psidium guajava L. with dichloromethane. The crude extract of Psidium guajava L. is fractionated to obtain multiple fractions. Identification and characterization of the multiple fractions are performed by using multiple chromatograms. USE – Method for obtaining guajadial molecule and its isomers used for producing drug composition and pharmaceutical composition for use in form of capsules, pills, tablets, paste or liquid for treatment of cancer (all claimed).
Main Application Field
B05 (Other organics – aromatics, aliphatic, organo-metallics, compounds whose substituents vary such that they would be classified in several of B01 – B05.); J01 (Separation – including evaporation, crystallisation, solvent extraction, chromatography, dialysis, osmosis including drying gases and/or vapours, and separation of solids from gases, liquids and other solids. Isotope separation, filter materials (including molecular sieves for separation), and centrifuges (except where used for analysis) (B01D, B03, B04, B07B).)
INVENTORS:
DE CARVALHO JOAO ERNESTO
RIZZO LARISSA YOKOTA
FOGLIO MARY ANN
TASCA GOIS RUIZ ANA LECIA
SARTORATTO ADILSON
FIGUEIRA GLYN MARA
NOGUEIRA EBERLIN MARCOS
METZE KONRADIN
398_GOIABA
Patent number: BR201003652-A2;BR201003652-E2
PATENT STATUS:
GRANTED
FOR ADDITIONAL INFORMATION:
parcerias@inova.unicamp.br
+55 (19) 3521-5207 / 2607
This technology profile has been automatically generated.